p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma

Oncogene. 1998 Aug 20;17(7):819-24. doi: 10.1038/sj.onc.1201993.

Abstract

The p53 tumor-suppressor gene is inactivated in over 50% of all human cancers. In normal cells, p53 induces growth arrest and apoptosis in response to DNA damage. We show that p53 acts as potent tumor-suppressor gene independent of its well-documented effects on tumor-cell proliferation and apoptosis. p53 activates target genes in a murine fibrosarcoma cell-line but does not affect tumor cell-cycle progression or survival. Exogenous expression of wt-p53 does, however, block the angiogenic potential of the tumor cells resulting in formation of dormant tumors in vivo. These data provide evidence that: (1) p53 acts as a tumor suppressor gene independent of its anti-proliferative effects; (2) By inhibiting angiogenesis p53 can indirectly induce apoptosis in vivo but not in vitro; (3) p53-gene therapy which alters a tumors angiogenic potential, can revert tumors to a dormant phenotype.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Cell Cycle
  • Cell Division
  • Cell Line
  • Chick Embryo
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / physiology
  • Fibrosarcoma / blood supply*
  • Fibrosarcoma / pathology*
  • Fibrosarcoma / secondary
  • Genes, p53*
  • Genetic Therapy
  • Humans
  • Lung Neoplasms / blood supply
  • Lung Neoplasms / pathology
  • Lung Neoplasms / secondary
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neovascularization, Pathologic / genetics*
  • Neovascularization, Pathologic / pathology
  • Transfection
  • Tumor Cells, Cultured